| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,994 |
3,533 |
$433K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,476 |
3,827 |
$331K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,016 |
957 |
$50K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
597 |
587 |
$46K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
412 |
412 |
$37K |
| 99385 |
|
279 |
274 |
$27K |
| 99215 |
Prolong outpt/office vis |
126 |
124 |
$21K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
139 |
137 |
$18K |
| 99401 |
|
1,288 |
1,119 |
$18K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
181 |
179 |
$17K |
| 36415 |
Collection of venous blood by venipuncture |
3,359 |
3,133 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
947 |
789 |
$8K |
| 99443 |
|
151 |
144 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
190 |
186 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
144 |
136 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
346 |
177 |
$5K |
| 99386 |
|
37 |
36 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
200 |
199 |
$3K |
| 81003 |
|
1,513 |
1,426 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
88 |
85 |
$3K |
| 90756 |
|
105 |
104 |
$2K |
| 96127 |
|
699 |
696 |
$2K |
| 81025 |
|
243 |
231 |
$2K |
| 99442 |
|
55 |
54 |
$2K |
| 90658 |
|
67 |
67 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$893.10 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
625 |
511 |
$834.93 |
| 83014 |
|
306 |
294 |
$478.18 |
| 87634 |
|
15 |
15 |
$417.45 |
| 82947 |
|
70 |
63 |
$214.57 |
| 99406 |
|
15 |
14 |
$131.89 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13 |
12 |
$82.80 |
| 3011F |
|
413 |
413 |
$0.72 |
| 3074F |
|
1,308 |
1,188 |
$0.61 |
| 3078F |
|
1,268 |
1,150 |
$0.58 |
| 1160F |
|
715 |
696 |
$0.19 |
| 3008F |
|
2,258 |
2,111 |
$0.16 |
| 3079F |
|
220 |
202 |
$0.13 |
| 3075F |
|
120 |
113 |
$0.09 |
| 4274F |
|
56 |
55 |
$0.09 |
| 3050F |
|
42 |
42 |
$0.06 |
| 4037F |
|
22 |
22 |
$0.02 |
| 3049F |
|
64 |
64 |
$0.02 |
| 3048F |
|
160 |
160 |
$0.02 |
| 1159F |
|
598 |
585 |
$0.02 |
| 3044F |
|
321 |
320 |
$0.00 |
| 1036F |
|
288 |
281 |
$0.00 |
| 1125F |
|
230 |
226 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
19 |
15 |
$0.00 |
| 1126F |
|
20 |
19 |
$0.00 |
| 99173 |
|
18 |
18 |
$0.00 |